Gilbert M. Rishton
Chief Tech/Sci/R&D Officer bij CARDAX, INC.
Profiel
Gilbert M.
Rishton was the founder of Cognition Therapeutics, Inc. (founded in 2007) and Channel Islands Alzheimer's Institute (founded in 2004) where he held the titles of Chief Chemistry Advisor and Director respectively.
Currently, he is the Chief Science Officer at Cardax, Inc. since 2008.
Previously, he worked as a Chemistry Manager at Amgen, Inc. from 1995 to 2004 and as the Chief Science Officer at Cardax Pharmaceuticals, Inc. He received his undergraduate degree from the University of Rhode Island in 1983 and his doctorate degree from Florida State University in 1988.
Actieve functies van Gilbert M. Rishton
| Bedrijven | Functie | Begin |
|---|---|---|
| CARDAX, INC. | Chief Tech/Sci/R&D Officer | 01-01-2008 |
Eerdere bekende functies van Gilbert M. Rishton
| Bedrijven | Functie | Einde |
|---|---|---|
| Channel Islands Alzheimer's Institute | Founder | 01-12-2010 |
| AMGEN INC. | Corporate Officer/Principal | - |
| COGNITION THERAPEUTICS, INC. | Founder | - |
Cardax Pharmaceuticals, Inc.
 Cardax Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cardax Pharmaceuticals, Inc. develops proprietary small molecule therapies for large unmet medical needs. It develops proprietary small molecule therapies for large unmet needs where oxidative stress and inflammation play important causative roles-including cardiovascular disease, hepatitis, macular degeneration and many cancers. The company's proprietary, synthetic, natural compound derivatives represent a novel treatment approach that offers efficacy along with an outstanding safety profile, oral bioavailability and tissue selectivity. Cardax Pharmaceuticals was founded by David G. Watumull and Samuelf Lockwood in May 2006 and is headquartered in Honolulu, HI. | Chief Tech/Sci/R&D Officer | - |
Opleiding van Gilbert M. Rishton
| University of Rhode Island | Undergraduate Degree |
| Florida State University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| COGNITION THERAPEUTICS, INC. | Health Technology |
| CARDAX, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Cardax Pharmaceuticals, Inc.
Cardax Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cardax Pharmaceuticals, Inc. develops proprietary small molecule therapies for large unmet medical needs. It develops proprietary small molecule therapies for large unmet needs where oxidative stress and inflammation play important causative roles-including cardiovascular disease, hepatitis, macular degeneration and many cancers. The company's proprietary, synthetic, natural compound derivatives represent a novel treatment approach that offers efficacy along with an outstanding safety profile, oral bioavailability and tissue selectivity. Cardax Pharmaceuticals was founded by David G. Watumull and Samuelf Lockwood in May 2006 and is headquartered in Honolulu, HI. | Health Technology |
| Channel Islands Alzheimer's Institute |
